ISRG Quote, Financials, Valuation and Earnings

Boston Scientific has a net margin of 28.41% compared to Intuitive Surgical's net margin of 12.41%. Intuitive Surgical's return on equity of 15.6% beat Boston Scientific's return on equity of 8.96%.

Intuitive Surgical has a consensus price target of $622.28, signalling upside risk potential of 22.73%. On the other hand Boston Scientific has an analysts' consensus of $115.46 which suggests that it could grow by 15.41%. Given that Intuitive Surgical has higher upside potential than Boston Scientific, analysts believe Intuitive Surgical is more attractive than Boston Scientific.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Boston Scientific has a beta of 0.728, suggesting its less volatile than the S&P 500 by 27.188%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Boston Scientific pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.4B, which are smaller than Boston Scientific quarterly revenues of $4.6B. Intuitive Surgical's net income of $685.7M is higher than Boston Scientific's net income of $566M. Notably, Intuitive Surgical's price-to-earnings ratio is 79.10x while Boston Scientific's PE ratio is 80.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.98x versus 8.88x for Boston Scientific. Usually stocks with elevated PS ratios are considered overvalued.

Integra Lifesciences Holdings has a net margin of 28.41% compared to Intuitive Surgical's net margin of 4.39%. Intuitive Surgical's return on equity of 15.6% beat Integra Lifesciences Holdings's return on equity of -0.45%.

Intuitive Surgical has a consensus price target of $622.28, signalling upside risk potential of 22.73%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $26.25 which suggests that it could grow by 20.52%. Given that Intuitive Surgical has higher upside potential than Integra Lifesciences Holdings, analysts believe Intuitive Surgical is more attractive than Integra Lifesciences Holdings.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.241, suggesting its more volatile than the S&P 500 by 24.12%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.4B, which are larger than Integra Lifesciences Holdings quarterly revenues of $442.6M. Intuitive Surgical's net income of $685.7M is higher than Integra Lifesciences Holdings's net income of $19.4M. Notably, Intuitive Surgical's price-to-earnings ratio is 79.10x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.98x versus 1.04x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Insulet has a net margin of 28.41% compared to Intuitive Surgical's net margin of 16.85%. Intuitive Surgical's return on equity of 15.6% beat Insulet's return on equity of 43.11%.

Intuitive Surgical has a consensus price target of $622.28, signalling upside risk potential of 22.73%. On the other hand Insulet has an analysts' consensus of $314.66 which suggests that it could grow by 16.92%. Given that Intuitive Surgical has higher upside potential than Insulet, analysts believe Intuitive Surgical is more attractive than Insulet.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Insulet has a beta of 1.300, suggesting its more volatile than the S&P 500 by 30.008%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Insulet offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Intuitive Surgical pays -- of its earnings as a dividend. Insulet pays out -- of its earnings as a dividend.

Intuitive Surgical quarterly revenues are $2.4B, which are larger than Insulet quarterly revenues of $597.5M. Intuitive Surgical's net income of $685.7M is higher than Insulet's net income of $100.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 79.10x while Insulet's PE ratio is 46.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.98x versus 9.60x for Insulet. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 28.41% compared to Intuitive Surgical's net margin of -17.18%. Intuitive Surgical's return on equity of 15.6% beat Teleflex's return on equity of 1.57%.

Intuitive Surgical has a consensus price target of $622.28, signalling upside risk potential of 22.73%. On the other hand Teleflex has an analysts' consensus of $165.22 which suggests that it could grow by 16.87%. Given that Intuitive Surgical has higher upside potential than Teleflex, analysts believe Intuitive Surgical is more attractive than Teleflex.

Intuitive Surgical has a beta of 1.555, which suggesting that the stock is 55.506% more volatile than S&P 500. In comparison Teleflex has a beta of 1.191, suggesting its more volatile than the S&P 500 by 19.095%.

Intuitive Surgical has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Teleflex offers a yield of 0.96% to investors and pays a quarterly dividend of $0.34 per share. Intuitive Surgical pays -- of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Teleflex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Intuitive Surgical quarterly revenues are $2.4B, which are larger than Teleflex quarterly revenues of $795.4M. Intuitive Surgical's net income of $685.7M is higher than Teleflex's net income of -$136.7M. Notably, Intuitive Surgical's price-to-earnings ratio is 79.10x while Teleflex's PE ratio is 99.56x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Intuitive Surgical is 21.98x versus 2.18x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.